Medical News Today -
24 Jan 2014 12:00
The findings of the scientists of the Institute of Diabetes and Regeneration Research (IDR) at Helmholtz Zentrum München (HMGU) provide new insights into the molecular regulation of stem cell differentiation. These results reveal important target structures for regenerative therapy approaches to chronic diseases such as diabetes.During embryonic development, organ-specific cell types are formed from pluripotent stem cells, which can differentiate into all cell types of the human body.
Share this Article